MARKET

KONEF

KONEF

Ketamineone Capital Limited
OTCMQB
0.0075
+0.0010
+15.38%
Closed 12:05 01/31 EST
OPEN
0.0075
PREV CLOSE
0.0065
HIGH
0.0075
LOW
0.0075
VOLUME
20.00K
TURNOVER
150
52 WEEK HIGH
2.600
52 WEEK LOW
0.0038
MARKET CAP
974.79K
P/E (TTM)
-0.0464
1D
5D
1M
3M
1Y
5Y
Women's Footprint In Psychedelics Is Undeniable, Benzinga's Psychedelics Advisory Council's Six New Trailblazers
Benzinga · 1d ago
First-Ever Clinical Trial On Magic Mushroom Therapy For Autism's Genetic Cause Receives Approval
Benzinga · 12/27/2022 17:47
BRIEF-Wellbeing Subsidiary KGK Science Receives Approval For First-Of-Its-Kind Psylocibin Clinical Trial
Reuters · 12/22/2022 21:17
BRIEF-Wellbeing Subsidiary KGK Science Awarded Cannabis Research License From Health Canada
Reuters · 12/08/2022 13:59
Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project
Benzinga · 12/06/2022 19:20
Wellbeing Subsidiary KGK Science Announces Successful Results of UP446, a Nutraceutical Ingredient, in Positive Immune Defense Response
VANCOUVER, British Columbia, December 06, 2022--Wellbeing Digital Sciences Inc. ("Wellbeing" or the "Company") (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clin...
Business Wire · 12/06/2022 12:30
EXCLUSIVE: MAPS To Host Major Psychedelics Event In 2023, Speakers & Details Below
Benzinga · 12/01/2022 12:57
Psychedelic Partnership To Test Psilocybin For FXS In First Phase 2 Clinical Trial
Benzinga · 11/30/2022 17:58
More
About KONEF
KetamineOne Capital Limited, formerly Myconic Capital Corp. is Canada-based wellness company. The Company is focused on assisted therapy and psychedelic medicines. The Company operates healthcare clinics across North America. The Company provides services for plant medicines, psychedelics, and mental health care. The Company is building a network of clinics with patient experiences. It is also developing wearable technologies to track specific and vital information for psychedelic therapies. The Company's wearables program allows clinicians to customize precise treatment plans by tracking key metrics such as sleep, exercise, heart rate, and mood, a patient is at home or in the clinic.

Webull offers kinds of KetamineOne Capital Ltd stock information, including OTCMQB:KONEF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KONEF stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading KONEF stock methods without spending real money on the virtual paper trading platform.